Table 3.
Hydrogen Peroxide (H2O2) | ||
---|---|---|
Before the initiation | 52nd week | |
Control vs. MTX | p < 0.05 * | p < 0.05 * |
Control vs. secukinumab | p < 0.05 * | p < 0.05 * |
Control vs. ustekinumab | p < 0.05 * | p < 0.05 * |
MTX vs. secukinumab | p > 0.05 | p > 0.05 |
MTX vs. ustekinumab | p > 0.05 | p > 0.05 |
Secukinumab vs. ustekinumab | p > 0.05 | p > 0.05 |
Catalase (CAT) | ||
Control vs. MTX | p < 0.01 ** | p < 0.01 ** |
Control vs. secukinumab | p < 0.01 ** | p < 0.01 ** |
Control vs. ustekinumab | p < 0.01 ** | p < 0.01 ** |
MTX vs. secukinumab | p > 0.05 | p < 0.05 * |
MTX vs. ustekinumab | p > 0.05 | p < 0.05 * |
Secukinumab vs. ustekinumab | p > 0.05 | p < 0.05 * |
Abbreviations: MTX—methotrexate.